Carcinoma: all 6,719 studies
Page 10 of 68. Open to participants first (1,142), then studies with results posted, then the rest; newest registration first within each.
- DEB-TACE+HAIC vs. HAIC for Large HCCRecruitingNCT05263219Phase 3
- Clinical Decision Biological Biomarker and Prognosis Prediction of Hepatocellular Carcinoma by Deep LearningRecruitingNCT05257694
- Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma PatientsRecruitingNCT05252078Phase 2
- Clinical Trial on HIPEC with Mitomycin C in Colon Cancer Peritoneal Metastases (GECOP-MMC)RecruitingNCT05250648Phase 4
- Immune System Modulation and Outcome in High-risk cSCC Treated With Surgery and RadiotherapyNot yet recruitingNCT05246228
- Sintilimab Plus NCT or NCRT Versus NCRT for ESCCNot yet recruitingNCT05244798Phase 3
- Study of an Artificial Human Skin Medicine for Patients With Basal Cell Carcinoma Undergoing Reconstructive SurgeryRecruitingNCT05234658Phase 2
- Early Salvage Therapy for Patients With Advanced Features for Biochemical Relapse After Radical Prostatectomy for Localized Prostate Carcinoma In Correlation With Supposed Molecular-genetic Parameters of Higher AggressivenessNot yet recruitingNCT05232578Phase 3
- Immunotherapy and Carbon Ion Radiotherapy In Solid Cancers With Stable DiseaseRecruitingNCT05229614Phase 2
- Safety and Efficacy of Lenvatinib and Anti-PD1 Antibody Combined With Radiotherapy Neoadjuvant Treatment for Resectable Hepatocellular Carcinoma With PVTTRecruitingNCT05225116Phase 1
- An Open-Label, Multiple-Center, Phase IIa/IIb Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of VG161 as Monotherapy and in Combination With Nivolumab for Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic CholangiocarcinomaRecruitingNCT05223816Phase 2
- A Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX07 Combination Therapy or Monotherapy in Patients With Advanced ESCCRecruitingNCT05221658Phase 2
- Cryoablation as a Minimally Invasive Alternative to Surgery for Managing Ductal Carcinoma In SituRecruitingNCT05218044Not applicable
- Novel Biomarkers of Hypoxia and Metabolism in Clear Cell Renal Cell CarcinomaRecruitingNCT05214885
- Penpulimab Plus Chemotherapy With/Without Anlotinib for Patients With Advanced Esophageal Squamous Cell CarcinomaRecruitingNCT05214222Phase 2
- A National Phase II Study of Proton Therapy in Hepatocellular CarcinomaRecruitingNCT05203120Not applicable
- Detection and Biopsy Guidance of Nasopharyngeal Carcinoma Based on Artificial Intelligence and Endoscopic ImagesRecruitingNCT05202626
- Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 CirrhosisRecruitingNCT05201404Phase 3
- Study of HBV-TCR T Cells (LioCyx-M) as Monotherapy or as Combination With Lenvatinib for HBV-related HCCNot yet recruitingNCT05195294Phase 2
- Study of Camrelizumab in Combination With Apatinib Mesylate Plus Albumin-bound Paclitaxel and Cisplatin as the First Line Treatment of Recurrent or Metastatic, UnresectableHead and Neck Squamous Cell CarcinomaNot yet recruitingNCT05189184Phase 2
- Perioperative Pembrolizumab and Lenvatinib in Resectable Hepatocellular Carcinoma (HCC)RecruitingNCT05185739Phase 2
- Ovarian Function of Nasopharyngeal Carcinoma Women SurvivorsNot yet recruitingNCT05183724
- Endostar Combined With Corticosteroid for Treatment of Radiation-induced Brain Necrosis in Nasopharyngeal CarcinomaRecruitingNCT05177237Phase 2
- Predictive Biomarkers in Patients With Advanced Hepatocellular Carcinoma Treated With Atezolizumab Plus BevacizumabRecruitingNCT05173298
- Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck CancerRecruitingNCT05172245Phase 1
- Induction Chemotherapy and Tazemetostat for Locally Advanced SMARCB1-deficient Sinonasal CarcinomaNot yet recruitingNCT05151588Phase 2
- A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid TumorsRecruitingNCT05150691Phase 1/2
- RAPA-201 Therapy of Solid TumorsRecruitingNCT05144698Phase 1/2
- Surgery Vs Chemoradiation for Oropharyngeal Cancer- A Phase II/III Integrated Design Randomized Control TrialNot yet recruitingNCT05144100Phase 2/3
- Assessment of the Safety and Tolerability of ex Vivo Next-generation Neoantigen-selected Tumor-infiltrating Lymphocyte (TIL) Therapy in Advanced Epithelial Tumors and Immune Checkpoint Blockade (ICB) Resistant Solid TumorsRecruitingNCT05141474Early Phase 1
- BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot StudyRecruitingNCT05136196Phase 2
- Registry Platform Ovarian and Endometrial CancerRecruitingNCT05129969
- Consolidative Radiotherapy Combined With Camrelizumab and Chemotherapy for Oligometastatic Nasopharyngeal CarcinomaRecruitingNCT05128201Phase 2
- Immune Score Based Radiomics in Nasopharyngeal CarcinomaRecruitingNCT05126160
- Neoadjuvant Anti-PD-1 and TP Versus TPF on Pathological Response in OSCCRecruitingNCT05125055Phase 2/3
- Individualized Dosimetry for Holmium-166-radioembolization in Patients With Unresectable Hepatocellular CarcinomaRecruitingNCT05114148Not applicable
- Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma of the Head and NeckRecruitingNCT05108090Not applicable
- Neoadjuvant Sintilimab Combined With Reduction of Cycles of Chemotherapy in Resectable Oral Cavity or Oropharyngeal Squamous Cell Carcinoma (OOC-002)RecruitingNCT05098119Phase 2
- Camrelizumab for the Treatment of Locally Advanced Nasopharyngeal CarcinomaRecruitingNCT05097209Phase 2
- Axitinib +/- Pembrolizumab in First Line Treatment of mPRCCRecruitingNCT05096390Phase 2
- Adaptive ChemoTherapy for Ovarian Cancer in Patients With Replased Platinum-sensitive High Grade Serous or High Grade Endometrioid Ovarian CancerRecruitingNCT05080556Phase 2
- Safety and Efficacy of Degradable Microsphere in Transcatheter Arterial Chemoembolization for Hepatocellular CarcinomaRecruitingNCT05072041Not applicable
- Neoadjuvant Personalized Anti-PD-1 and Anti-VEGFR Therapy in OSCC PatientsRecruitingNCT05069857Phase 2
- Neoadjuvant DaRT for Locally Advanced Oral Cavity SCCNot yet recruitingNCT05065346Not applicable
- ICCRT vs. CRT for Locally Advanced Nasopharyngeal CarcinomaRecruitingNCT05062005Phase 3
- Cryoablation Combined with Tislelizumab Plus Lenvatinib As Second-line or Later Therapy in Advanced Hepatocellular CarcinomaRecruitingNCT05057845Phase 2
- Regorafenib Combined With PD-1 Inhibitor Therapy for Second-line Treatment of Hepatocellular CarcinomaRecruitingNCT05048017Phase 2
- GPC3 Targeted Fluorescence Image Guided Surgery of Hepatocellular CarcinomaRecruitingNCT05047510Not applicable
- Single-agent Capecitabine as Metronomic Chemotherapy in LAHNSCC (CMHN)RecruitingNCT05044117Phase 3
- Clinical Study of Radiotherapy Combined With Nedaplatin Contrast and Cisplatin for the Treatment of Locally Advanced Head and Neck Squamous CarcinomaNot yet recruitingNCT05039606Phase 2
- The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid TumorsRecruitingNCT05037825
- Hyperbaric Oxygen Therapy Combined Camrelizumab in Patients With Advanced/Metastatic Hepatocellular CarcinomaRecruitingNCT05031949Phase 1
- Neoadjuvant Pembrolizumab in Cutaneous Squamous Cell CarcinomaRecruitingNCT05025813Phase 2
- NeoAdjuvant Pembrolizumab and STEreotactic Radiotherapy Prior to Nephrectomy for Renal Cell CarcinomaRecruitingNCT05024318Phase 2
- Nimotuzumab Combined With Radiotherapy in High-risk Patients With HNSCC Not Suitable for Cisplatin After SurgeryNot yet recruitingNCT05024019Phase 2
- A Phase 3 Study to Evaluate Surufatinib Plus Toripalimab in the Treatment of Advanced Neuroendocrine CarcinomaRecruitingNCT05015621Phase 3
- Camrelizumab and Chemotherapy Combined With Endoscopic Surgery for Recurrent Nasopharyngeal CarcinomaRecruitingNCT05011227Phase 2
- Observational Study of Factors Predicting Therapeutic Effects and Clinical Prognosis After HAIC for Locally Advanced HCCRecruitingNCT05002452
- Urothelial Tumor Risk Genes Detection With Genetron Uro V1 and LC-WGSRecruitingNCT04994197
- A Study of Toripalimab as Consolidation Therapy After Postoperative Chemoradiotherapy in HNSCCRecruitingNCT04992559Phase 2
- Accelerated Partial Breast Irradiation (APBI) Using Stereotactic Body Radiation Therapy (SBRT)RecruitingNCT04985032
- Fluzoparib and Camrelizumab in Treating Patients With R/M NPC That Progressed After First-line ChemotherapyRecruitingNCT04978012Phase 2
- Study of Nimotuzumab Combined With IMRT in Elder Patients With Cervical Squamous Cell CarcinomaNot yet recruitingNCT04976478
- Tyrosine Kinase Inhibitors in Metastastic Adenoid Cystic CarcinomaRecruitingNCT04974866Phase 2
- Neoadjuvant Immunotherapy Plus CRT Versus Neoadjuvant CRT for Locally Advanced Resectable ESCCRecruitingNCT04973306Phase 2/3
- Clinical Study of CAIX-targeted CAR-T Cells in the Treatment of Advanced Renal Cell CarcinomaRecruitingNCT04969354Phase 1
- TACE Plus Multikinase Inhibitor and I-125 Seeds Brachytherapy for HCC With Branch PVTTRecruitingNCT04967495Not applicable
- A Study of Sintilimab in Combination With Axitinib in Advanced Renal Cell CancerNot yet recruitingNCT04958473Phase 2
- Diagnostic Evaluation of Urine DNA Methylation/Somatic Mutation Profiling for Upper Tract Urothelial Carcinoma DetectionRecruitingNCT04948528
- Camrelizumab in Patients With Unresectable Hepatocellular CarcinomaNot yet recruitingNCT04947956
- Combination of Metronomic Capecitabine With Camrelizumab for Treatment of Refractory Solid Tumor Trial (Cohort 3)RecruitingNCT04932187Phase 1
- Induction Versus Adjuvant Gemcitabine/Cisplatin in Locally Advanced Non-metastatic Nasopharyngeal CarcinomaRecruitingNCT04898374Phase 3
- B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)RecruitingNCT04897321Phase 1
- Combination of Spartalizumab, mDCF and Radiotherapy in Patients With Metastatic Squamous Cell Anal CarcinomaRecruitingNCT04894370Phase 2
- An Open-label, Multicentre, Phase II/III RCT of PFLL Versus GP Combined With JS001 as the First-line Therapy for mNPCNot yet recruitingNCT04890522Phase 2/3
- Toripalimab Based Induction Chemotherapy Followed by De-escalation Protocols in HPV-related OPSCCRecruitingNCT04867330Not applicable
- Study of Pembrolizumab Combined with Chemotherapy in the First Line Therapy for R/M HNSCC in ChinaRecruitingNCT04857164Phase 2
- IFx-Hu2.0 Expanded Access ProgramAvailableNCT04853602
- Laparoscopic Versus Open Major Hepatectomy for HCC Hepatectomy for Hepatocellular CarcinomaRecruitingNCT04852211Not applicable
- A Study of Maintenance DCVAC/OvCa After First-line Chemotherapy Added Standard of CareRecruitingNCT04834544Phase 2
- The Efficacy of Camrelizumab Plus Stereotactic Body Radiotherapy in R/M NPCRecruitingNCT04830267Phase 2
- Hepatic Intra-Arterial Administration of Ipilimumab in Combination With Intra-venous Nivolumab for Advanced Hepatocellular CarcinomaRecruitingNCT04823403Phase 1
- 18F-FDG PET/CT Guided Reduced-dose Radiotherapy for Nasopharyngeal CarcinomaRecruitingNCT04813705Phase 2
- Pembrolizumab Plus Neoadjuvant Chemotherapy vs. Neoadjuvant Chemoradiotherapy for Locally Advanced ESCC (KEYSTONE-002)RecruitingNCT04807673Phase 3
- The ABC-HCC Trial: Atezolizumab Plus Bevacizumab vs. Transarterial Chemoembolization (TACE) in Intermediate-stage HepatoCellular CarcinomaRecruitingNCT04803994Phase 3
- The Role Of Circulating Tumor Cells As Markers Of Advanced Disease And Prognosis In HCCRecruitingNCT04800497
- Electromagnetic Fields Versus Placebo For Child-Pugh A and B Patients With Advanced Hepatocellular CarcinomaRecruitingNCT04797884Phase 2/3
- Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast CancerRecruitingNCT04790305Phase 4
- Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067RecruitingNCT04787042Phase 1/2
- Toripalimab Plus Surgery vs Surgery Alone for Resectable Recurrent Nasopharyngeal CarcinomaRecruitingNCT04778956Phase 3
- Neo-TACE-HAIC for High-risk BCLC A Stage HCC (NeoconceptA)RecruitingNCT04777942Not applicable
- The Paclitaxel (Albumin-bound) Combined With Cisplatin, PD-1 Inhibitors and IMRT in the Treatment of Nasopharyngeal CarcinomaNot yet recruitingNCT04769076Phase 2
- Paclitaxel (Albumin-bound) Combined With Radiotherapy for the Treatment of Early Stage Nasopharyngeal CarcinomaNot yet recruitingNCT04766359Phase 3
- A Web-mediated Follow-up With the Web-application KidneyPRO Versus Standard Follow-up for Patients With Advanced Renal Cell Carcinoma Treated With Axitinib/Pembrolizumab in First LineRecruitingNCT04764487Phase 3
- Efficacy and Safety of Almonertinib Combined With or Without Chemotherapy as an Adjuvant Treatment for Stage II-IIIA Non-small Cell Lung Carcinoma Following Complete Tumour ResectionEnrolling by invitationNCT04762459Phase 3
- A Safety and Efficacy Study of Intra-tumoural Diffusing Alpha Radiation Emitters for the Treatment of Vulva CancerRecruitingNCT04761146Not applicable
- Study on the Efficacy of Treatment by Radiotherapy and Pembrolizumab in Newly Diagnosed Metastatic Head & Neck CancersRecruitingNCT04747054Phase 3
- Redirected HBV-Specific T Cells in Patients With HBV-related HCC (SAFE-T-HBV)RecruitingNCT04745403Phase 1
- Standard Versus Radiobiologically-Guided Dose Selected SBRT in Liver CancerRecruitingNCT04745390Not applicable
- Efficacy and Safety of TACE on Downstaging Hepatocellular Carcinoma Beyond UCSF Criteria;RecruitingNCT04738188Not applicable